Biologics Manufacturing DACH unites senior leaders and manufacturing experts to explore how the DACH region can lead the next wave of biologics production.
The programme spans upstream and downstream innovations, process intensification, and the latest continuous manufacturing strategies.
With the global biologics market expected to surpass $600 billion by 2030, driven by the rise of next-generation modalities and rapid advances in manufacturing technologies, Biologics Manufacturing DACH 2026 offers a premier platform for industry leaders to explore innovation, share expertise, and build strategic partnerships.
As the DACH region strengthens its role as a hub for cutting-edge biologics production, this conference brings together manufacturers, technology providers, and developers to tackle the industry’s most pressing challenges in a focused, highly networked setting.
From senior leaders shaping microbial platforms and CMC strategies to experts advancing upstream and downstream process innovation. Representing some of the most influential biopharma companies in the DACH region and beyond, this is where decision-makers, process engineers, quality champions, and technology disruptors converge to shape the future of biomanufacturing.
A conference dedicated to focusing exclusively on scaling next-generation biologics manufacturing.
It will bring together leaders in upstream & downstream process innovation, continuous manufacturing, automation & AI, single-use technologies, and facility scale-up to address the region’s most pressing challenges and opportunities in biologics production.
Essentially, it’s the go-to DACH-region platform for biopharma manufacturers, CDMOs, and tech providers to share insights, showcase innovations, and forge strategic partnerships in the biologics manufacturing space.
It’s laser-focused on next-gen biologics in the DACH region, bringing together the exact mix of regional decision-makers, global innovators, and hands-on technical leaders you need to move from discussion to implementation.
Not a crowded expo floor, no endless panels – but a highly curated, intimate environment where every conversation is relevant and every connection is actionable. You’ll hear first-hand, real-world strategies from the people actually scaling, intensifying, and transforming biologics manufacturing right now.
Key Themes & Topics
Scaling Next-Gen Biologics in DACH
Commercialisation, regional capacity planning, and partnership strategies to move monoclonals, bispecifics and novel protein formats from clinical batches to reliable commercial supply across Germany, Austria and Switzerland.
Industry Roundtables: Future of Biomanufacturing
Peer-led, interactive sessions on regional opportunities, investment models, workforce readiness and coordinated capacity expansion.
Upstream Process Intensification
High-productivity fed-batch and perfusion approaches, media and cell line strategies, and PAT-enabled control to boost titres and reduce cycle time.
Advances in Downstream Processing
Continuous chromatography, novel capture/resin technologies and filtration strategies to improve yield, purity and throughput for complex molecules.
Continuous Manufacturing
Practical case studies on batch→continuous transitions, integration challenges, control strategies and commercial scale readiness.
Single-Use Technologies vs Stainless Steel
Decision frameworks for hybrid facility design - cost, sustainability, contamination risk, long-term flexibility and total cost of ownership.
Automation & AI in Biologics Manufacturing
MES/LIMS integration, digital twins, PAT and AI for predictive control, real-time release and maintenance optimisation.
Scaling Platforms & Facilities for Future Modalities
Modular cleanrooms, multiproduct sites and platform strategies that future-proof facilities for emerging modalities and multi-asset production.
200+
Senior Attendees
Join the DACH region’s most focused forum for biologics manufacturing, where upstream scientists, downstream engineers, and manufacturing strategists come together to tackle the realities of scaling next-gen biologics. From intensifying fed-batch processes to implementing hybrid single-use/stainless strategies, this is where technical depth meets commercial focus.
30+
Expert Speakers
Hear from the experts' driving breakthroughs in process intensification, continuous manufacturing, and automation— plus fresh case studies on facility design for multi-modality production. Get actionable insights you won’t find in broad, generalist events.
20+
Companies Represented
Build connections with the people making the region’s biologics production capacity future-ready: CDMOs expanding microbial and mammalian platforms, innovators integrating AI into quality systems, and technology providers solving real bottlenecks.
